Phaco Reloaded: Level Up Your Cataract Game

This supplement summarizes a discussion among cataract surgeons on fluidics-driven phacoemulsification and innovations in cataract surgery. Faculty experts share clinical experiences and insights into phaco techniques, fluidics systems, and intraocular lens implantation.

ReachMD Healthcare Image
Details
  • Overview

    This supplement summarizes a discussion among cataract surgeons on fluidics-driven phacoemulsification and innovations in cataract surgery. Faculty experts share clinical experiences and insights into phaco techniques, fluidics systems, and intraocular lens implantation.  

  • Target Audience

    This certified CME activity is designed for cataract and refractive surgeons, as well as ophthalmologists involved in the surgical management of cataracts.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Manage machine fluidics to enhance chamber stability and minimize complications during cataract surgery
    • Assess ergonomic innovations in phacoemulsification systems that reduce surgeon fatigue and improve procedural precision
    • Propose surgical techniques for managing complex cataracts 
  • Grantor Statment

    This activity is supported by an unrestricted educational grant from Johnson & Johnson Surgical Vision.

  • Accreditation and Credit Designation Statements

    Provided by Evolve Medical Education  
     

    Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

  • Faculty

    Eric Donnenfeld, MD, Moderator 
    Clinical Professor of Ophthalmology  
    NYU 
    New York, NY 
     
    Marjan Farid, MD 
    Health Sciences Clinical Professor
    University of California
    Gavin Herbert Eye Institute 
    Irvine, CA
     
    Jason Jones, MD
    Jones Eye Clinic and Surgery Center
    Sioux City, Iowa

    Eva Liang, MD 
    Ophthalmologist
    Center for Sight 
    Las Vegas, NV 
     
    Carlton Yuen, MD 
    Ophthalmologist
    Aloha Vision Consultants 
    Honolulu, HI

  • Disclosure of Relevant Financial Relationships

    DISCLOSURE POLICY
    In accordance with the ACCME Standards for Integrity and Independence, it is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.

    The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.

    Eric Donnenfeld, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Abbvie, Allegro, Alcon, AVTRMed, Aurion, Bausch & Lomb, BlephEx, BVI, CorneaGen, Covalent, CRST, Crystilex, ELT Sight, EyePoint Pharma, Foresight, Glaukos, Horizon Surgical Systems, Inversa, Johnson & Johnson, Kala, Katena, Lacripen, LayerBio, LensGen, Mati Pharmaceuticals, MDBackline, MOA, Nordic Pharma, Novabay, Ocular Innovations, Oculis, Ocuhub, Omega Ophthalmics, PRN, Rayner, ReTear, Singular, Strathspey Crown, Surface, Tarsus, Tearscience, Tenpoint Pharma, Versant Ventures, Visionary Venture, and Zeiss. Owner/ Employee: Aurion, AVTRMed, CorneaGen, Covalent, Crystilex, ELT Sight, EyePoint Pharma, Glaukos, Horizon Surgical Systems, Inversa, Ivantis, Lacripen, LayerBio, LensGen, Mati Pharmaceuticals, MDBackline, MOA, Ocuhub, Ocular Innovations, Oculis, Rayner, ReTear, Singular, Strathspey Crown, Surface, Tarsus, TenPoint, Veracity, Versant Ventures, and Visionary Ventures. 

    Marjan Farid, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AcuFocus, Alcon, Alderya Therapeutics, Inc., Allergan, Bausch + Lomb, Bio-Tissue, Inc., CorneaGen, Dompe, Glaukos, Johnson & Johnson Vision, Kala Pharmaceuticals, Inc., Novartis, Alcon Pharmaceuticals, Orasis, Oyster Point, Sun Ophthalmics, Tarsus, and Zeiss. 
     
    Jason Jones, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon Vision, LLC, Glaukos, Johnson & Johnson Surgical Vision, Inc., Perfect Lens, and Spyglass. Grant/Research Support: Alcon Vision, LLC, Glaukos, Johnson & Johnson Surgical Vision, Inc., and Spyglass. Speaker's Bureau: Johnson & Johnson Surgical Vision, Inc.
     
    Eva Liang, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Bausch + Lomb, Glaukos Corporation, Novaliq, and Sanoculis. Grant / Research Support: Alcon Laboratories, Inc., Bausch + Lomb, BVI, Cloudbreak, ELIOS Vision, Glaukos Corporation, iSTAR Medical, Johnson & Johnson Vision, Novaliq, Oculis, Oyster Point Pharma, Palatin, Rayner Intraocular Lenses Ltd, RxSight Inc, Sanoculis, Twenty Twenty Therapeutics, and VIVAVISION. Speaker's Bureau: Alcon Laboratories, Inc., Bausch + Lomb, Glaukos Corporation, and Johnson & Johnson Vision. 
     
    Carlton Yuen, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Johnson & Johnson Surgical Vision, Inc. Grant/Research Support: Johnson & Johnson Surgical Vision, Inc. Speaker's Bureau: Alcon Vision, LLC, Dompe, and Johnson & Johnson Surgical Vision, Inc. 

    The Evolve, planners, reviewer, and writers have no financial relationships with ineligible companies.  

  • Disclaimer

    OFF-LABEL STATEMENT
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    DISCLAIMER
    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Retina Today, or Genentech.

    This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

  • Publication Dates

    Expiration Date:

1.00 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Register

We're glad to see you're enjoying Evolve Medical Education…
but how about a more personalized experience?

Register for free